Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123318982 | 12331898 | 2 | F | 20160420 | 20160726 | 20160504 | 20160808 | EXP | US-PFIZER INC-2016127943 | PFIZER | 67.00 | YR | M | Y | 0.00000 | 20160808 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123318982 | 12331898 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, 1X/DAY | 21938 | 50 | MG | CAPSULE, HARD | QD | ||||||
| 123318982 | 12331898 | 2 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123318982 | 12331898 | 1 | Metastatic renal cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123318982 | 12331898 | DE |
| 123318982 | 12331898 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123318982 | 12331898 | Deafness | |
| 123318982 | 12331898 | Death | |
| 123318982 | 12331898 | Ear disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123318982 | 12331898 | 1 | 201603 | 0 | ||
| 123318982 | 12331898 | 2 | 20160420 | 20160509 | 0 |